Found: 50
Select item for more details and to access through your institution.
Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1117, doi. 10.1007/s00280-011-1808-4
- By:
- Publication type:
- Article
A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1127, doi. 10.1007/s00280-011-1805-7
- By:
- Publication type:
- Article
Exposure-response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selection.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1135, doi. 10.1007/s00280-011-1787-5
- By:
- Publication type:
- Article
Mass balance, excretion and metabolism of [(14)C] ASA404 in cancer patients in a phase I trial.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Mass balance, excretion and metabolism of [C] ASA404 in cancer patients in a phase I trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1145, doi. 10.1007/s00280-011-1809-3
- By:
- Publication type:
- Article
Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1155, doi. 10.1007/s00280-011-1800-z
- By:
- Publication type:
- Article
Addition of rituximab to reduced-dose CHOP chemotherapy is feasible for elderly patients with diffuse large B-cell lymphoma.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Addition of rituximab to reduced-dose CHOP chemotherapy is feasible for elderly patients with diffuse large B-cell lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1165, doi. 10.1007/s00280-011-1814-6
- By:
- Publication type:
- Article
Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1173, doi. 10.1007/s00280-011-1810-x
- By:
- Publication type:
- Article
Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002)
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1181, doi. 10.1007/s00280-011-1818-2
- By:
- Publication type:
- Article
The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1189, doi. 10.1007/s00280-011-1815-5
- By:
- Publication type:
- Article
Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1197, doi. 10.1007/s00280-012-1822-1
- By:
- Publication type:
- Article
Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1205, doi. 10.1007/s00280-012-1823-0
- By:
- Publication type:
- Article
The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1213, doi. 10.1007/s00280-012-1828-8
- By:
- Publication type:
- Article
Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1221, doi. 10.1007/s00280-011-1816-4
- By:
- Publication type:
- Article
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1229, doi. 10.1007/s00280-011-1817-3
- By:
- Publication type:
- Article
A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1241, doi. 10.1007/s00280-012-1831-0
- By:
- Publication type:
- Article
The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1247, doi. 10.1007/s00280-011-1819-1
- By:
- Publication type:
- Article
Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1255, doi. 10.1007/s00280-012-1825-y
- By:
- Publication type:
- Article
Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1265, doi. 10.1007/s00280-012-1833-y
- By:
- Publication type:
- Article
RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1277, doi. 10.1007/s00280-012-1834-x
- By:
- Publication type:
- Article
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1289, doi. 10.1007/s00280-012-1829-7
- By:
- Publication type:
- Article
Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1301, doi. 10.1007/s00280-011-1811-9
- By:
- Publication type:
- Article
Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1307, doi. 10.1007/s00280-012-1835-9
- By:
- Publication type:
- Article
Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1315, doi. 10.1007/s00280-012-1830-1
- By:
- Publication type:
- Article
Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1323, doi. 10.1007/s00280-012-1827-9
- By:
- Publication type:
- Article
Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1333, doi. 10.1007/s00280-012-1836-8
- By:
- Publication type:
- Article
A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1339, doi. 10.1007/s00280-012-1843-9
- By:
- Publication type:
- Article
A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1345, doi. 10.1007/s00280-012-1824-z
- By:
- Publication type:
- Article
Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1353, doi. 10.1007/s00280-012-1844-8
- By:
- Publication type:
- Article
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1363, doi. 10.1007/s00280-012-1841-y
- By:
- Publication type:
- Article
Analysis of the pharmacodynamic activity of the mTOR inhibitor ridaforolimus (AP23573, MK-8669) in a phase 1 clinical trial.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Analysis of the pharmacodynamic activity of the mTOR inhibitor ridaforolimus (AP23573, MK-8669) in a phase 1 clinical trial.
- Published in:
- 2012
- By:
- Publication type:
- Report
Phase I and pharmacologic study of weekly amrubicin in patients with refractory or relapsed lung cancer: Central Japan Lung Study Group (CJLSG) 0601 trial.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Phase I and pharmacologic study of weekly amrubicin in patients with refractory or relapsed lung cancer: Central Japan Lung Study Group (CJLSG) 0601 trial.
- Published in:
- 2012
- By:
- Publication type:
- Report
Prognostic significance of MRP5 immunohistochemical expression in glioblastoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1387, doi. 10.1007/s00280-012-1832-z
- By:
- Publication type:
- Article